Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness

Sponsor
Beijing Tiantan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05823454
Collaborator
(none)
200
1
42
4.8

Study Details

Study Description

Brief Summary

Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness based on Electroencephalography and Auditory Event-related Potentials

Condition or Disease Intervention/Treatment Phase
  • Drug: Different drug dosage

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness Based on Electroencephalogram and Event-related Potential
Actual Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2025
Anticipated Study Completion Date :
Mar 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Propofol

Intravenous infusion

Drug: Different drug dosage
Choice of Anesthesia

Dexmedetomidine

Intravenous infusion

Drug: Different drug dosage
Choice of Anesthesia

Esketamine

Intravenous infusion

Drug: Different drug dosage
Choice of Anesthesia

Sevoflurane

Inhalation anesthesia

Drug: Different drug dosage
Choice of Anesthesia

Remifentanil

Intravenous infusion

Drug: Different drug dosage
Choice of Anesthesia

Outcome Measures

Primary Outcome Measures

  1. EEG Spectral Characteristics [During the trial(up to 3 hours for each subject)]

    Characteristics of EEG power spectrum(for 1-30 Hz) in patients with chronic consciousness disorder under different doses of drugs

Secondary Outcome Measures

  1. Cortical Connectivity [During the trial(up to 3 hours for each subject)]

    Characteristics of the weighted phase lag index in patients with chronic consciousness

  2. Derived quantitative indicators [During the trial(up to 3 hours for each subject)]

    Characteristics of EEG derived quantitative indicators with chronic consciousness disorder during anesthesia recovery

  3. Characteristics of sleep [During the trial(up to 24 hours for each subject)]

    Characteristics of sleep cycle in patients with chronic disorders of consciousness

  4. Dynamic Patterns of Cortical Connectivity [During the trial(up to 3 hours for each subject)]

    The time-frequency characteristics of the weighted phase lag index in patients with chronic disorders of consciousness

  5. Rate of patients recovered consciousness after surgery [During the trial(through study completion, 180 days)]

    Rate of patients recovered consciousness 30 days, 90 days, 180 days after surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 18 - 65 years old, native Chinese speaker, dextromanuality;

  • Chronic disorder of consciousness;

  • Spinal cord electrical stimulator implantation under general anesthesia;

  • Signed informed consent.

Exclusion Criteria:
  • Continuous sedation was administered within 72 hours prior to the study;

  • Open head injury, parenchymatectomy and other damage of brain structural integrity;

  • The intracranial compliance decreased due to hydrocephalus and swelling;

  • Known hearing impairment;

  • Airway stenosis and various causes of severe ventilation or ventilation dysfunction;

  • Known or suspected cardiac dysfunction;

  • Allergic to intravenous general anesthetics;

  • Associated with other mental or neurological diseases;

  • Other reasons are not suitable to participate in this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beijing Tiantan Hospital, Capital Medical University Beijing China 100070

Sponsors and Collaborators

  • Beijing Tiantan Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ruquan Han, Professor, Beijing Tiantan Hospital
ClinicalTrials.gov Identifier:
NCT05823454
Other Study ID Numbers:
  • ywn20220929
First Posted:
Apr 21, 2023
Last Update Posted:
Apr 21, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ruquan Han, Professor, Beijing Tiantan Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2023